secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001193125-25-321738
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar exchanges 2.5M common shares for 250K convertible preferred with Blue Owl
--------------------------------------------------------------------------------

- Blue Owl Healthcare exchanged 2,500,000 common shares for 250,000 Series A convertible preferred shares.
- Each preferred share converts into 10 common shares (2.5M total); conversion blocker set at 9.99%.
- Preferred stock has no voting rights except on amendments; ranks pari passu with common on liquidation.
- Exchange executed under Section 3(a)(9) exemption; no commissions paid.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000119312525321738/0001193125-25-321738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000119312525321738/d42051d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-321738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer